Share Price and Basic Stock Data
Last Updated: November 15, 2025, 10:53 pm
| PEG Ratio | 0.25 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Dai Ichi Karkaria Ltd operates in the specialty chemicals segment, focusing on a variety of chemical products. The company reported a market capitalization of ₹201 Cr and a share price of ₹270. Over the past financial years, Dai Ichi Karkaria’s revenue from operations has shown fluctuations, with sales recorded at ₹184 Cr for FY 2023, declining to ₹132 Cr in FY 2024 before recovering to ₹181 Cr in FY 2025. The trailing twelve-month (TTM) sales stood at ₹187 Cr, indicating a slight recovery in the company’s performance. Quarterly sales also exhibited variability, peaking at ₹70.06 Cr in March 2025, while the most recent quarter (June 2023) recorded sales of ₹27.86 Cr, suggesting a challenging start to the fiscal year. Such trends highlight the company’s struggle to maintain consistent revenue growth amidst market dynamics.
Profitability and Efficiency Metrics
The profitability of Dai Ichi Karkaria has been inconsistent, with operating profit margins (OPM) fluctuating significantly. For FY 2025, the OPM was reported at 8%, a recovery from the negative margins observed in previous years, particularly the OPM of -15% in FY 2022. The net profit for FY 2025 stood at ₹9 Cr, translating to an earnings per share (EPS) of ₹12.11, down from ₹26.94 in FY 2023. The return on equity (ROE) was reported at 4.20%, while return on capital employed (ROCE) was slightly better at 4.29%. The company’s interest coverage ratio (ICR) of 10.34x indicates a strong ability to meet interest obligations, suggesting some operational efficiency. However, the overall low profitability metrics compared to industry standards raise concerns regarding sustainability and competitive positioning.
Balance Sheet Strength and Financial Ratios
Dai Ichi Karkaria’s balance sheet reflects a cautious approach to debt management, with total borrowings recorded at ₹13 Cr against reserves of ₹181 Cr, indicating a healthy reserves-to-borrowing ratio. The company maintains a current ratio of 1.69, which is above the typical sector benchmark, suggesting adequate liquidity to cover short-term liabilities. The price-to-book value ratio stood at 0.94x, indicating that the stock is trading below its book value, which could imply potential undervaluation. However, with a total debt-to-equity ratio of 0.06, the company has minimal leverage, which is favorable for risk management. Despite these strengths, the declining trend in profitability and the fluctuations in revenue raise questions about the company’s operational resilience moving forward.
Shareholding Pattern and Investor Confidence
The shareholding structure of Dai Ichi Karkaria reveals a significant promoter stake of 63.98%, which has remained stable over recent quarters. The public holds 36.02% of the shares, reflecting a healthy distribution of ownership. However, foreign institutional investors (FIIs) have not participated, and domestic institutional investors (DIIs) have a negligible presence, with their stake recorded at 0.00%. This lack of institutional backing may reflect a cautious sentiment towards the company’s growth prospects among larger investors. The total number of shareholders has increased to 6,121, indicating a growing interest among retail investors. The stability in promoter holdings, coupled with a slight increase in public participation, suggests a moderate level of investor confidence, although the absence of institutional interest could be a potential red flag for future capital raising efforts.
Outlook, Risks, and Final Insight
The outlook for Dai Ichi Karkaria is mixed. On one hand, the recovery in sales to ₹181 Cr for FY 2025 and improved operating margins signal potential for growth. On the other hand, the company faces challenges such as inconsistent profitability and a lack of institutional support, which could hinder its ability to capitalize on market opportunities. Risks include dependency on specific market segments, fluctuations in raw material costs, and overall economic conditions affecting the specialty chemicals sector. The company must focus on improving operational efficiencies and diversifying its product offerings to mitigate these risks. In scenarios where Dai Ichi Karkaria successfully enhances its profitability metrics and attracts institutional investors, it could see a more favorable market positioning. Conversely, continued volatility in revenues and profitability may limit its growth potential and shareholder value in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Dai Ichi Karkaria Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 438 Cr. | 47.6 | 86.7/42.6 | 27.2 | 20.5 | 0.84 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.6 Cr. | 74.5 | 103/56.0 | 17.5 | 89.6 | 1.34 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.4 Cr. | 712 | 988/0.00 | 22.3 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,702 Cr. | 81.6 | 111/78.0 | 24.5 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 709 Cr. | 284 | 453/241 | 25.4 | 93.8 | 0.88 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,799.08 Cr | 738.54 | 64.23 | 182.82 | 0.41% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.28 | 54.32 | 48.88 | 42.46 | 27.86 | 35.05 | 35.27 | 33.40 | 33.86 | 36.75 | 40.71 | 70.06 | 39.45 |
| Expenses | 39.43 | 48.98 | 42.25 | 37.38 | 28.44 | 33.42 | 32.82 | 30.61 | 31.92 | 35.04 | 37.97 | 61.99 | 38.17 |
| Operating Profit | -1.15 | 5.34 | 6.63 | 5.08 | -0.58 | 1.63 | 2.45 | 2.79 | 1.94 | 1.71 | 2.74 | 8.07 | 1.28 |
| OPM % | -3.00% | 9.83% | 13.56% | 11.96% | -2.08% | 4.65% | 6.95% | 8.35% | 5.73% | 4.65% | 6.73% | 11.52% | 3.24% |
| Other Income | 1.27 | 9.28 | 4.85 | 1.32 | 0.98 | 21.47 | 0.66 | 1.26 | 0.66 | 1.12 | 2.80 | 1.41 | 0.79 |
| Interest | 0.67 | 0.68 | 0.63 | 1.06 | 1.18 | 0.97 | 0.47 | 0.44 | 0.47 | 0.50 | 0.45 | 0.41 | 0.24 |
| Depreciation | 1.71 | 1.73 | 1.85 | 2.16 | 2.29 | 2.30 | 2.35 | 2.29 | 2.49 | 2.58 | 2.54 | 2.54 | 2.52 |
| Profit before tax | -2.26 | 12.21 | 9.00 | 3.18 | -3.07 | 19.83 | 0.29 | 1.32 | -0.36 | -0.25 | 2.55 | 6.53 | -0.69 |
| Tax % | 0.00% | 0.00% | 0.00% | 114.47% | -4.89% | 25.26% | -103.45% | 24.24% | -25.00% | 48.00% | 25.10% | 24.81% | -26.09% |
| Net Profit | -1.93 | 12.28 | 9.18 | 0.57 | -2.90 | 14.60 | 1.11 | 1.09 | 0.43 | -0.23 | 2.62 | 6.20 | 0.02 |
| EPS in Rs | -2.59 | 16.48 | 12.32 | 0.76 | -3.89 | 19.59 | 1.49 | 1.46 | 0.58 | -0.31 | 3.52 | 8.32 | 0.03 |
Last Updated: August 19, 2025, 8:30 pm
Below is a detailed analysis of the quarterly data for Dai Ichi Karkaria Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 39.45 Cr.. The value appears to be declining and may need further review. It has decreased from 70.06 Cr. (Mar 2025) to 39.45 Cr., marking a decrease of 30.61 Cr..
- For Expenses, as of Jun 2025, the value is 38.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 61.99 Cr. (Mar 2025) to 38.17 Cr., marking a decrease of 23.82 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.28 Cr.. The value appears to be declining and may need further review. It has decreased from 8.07 Cr. (Mar 2025) to 1.28 Cr., marking a decrease of 6.79 Cr..
- For OPM %, as of Jun 2025, the value is 3.24%. The value appears to be declining and may need further review. It has decreased from 11.52% (Mar 2025) to 3.24%, marking a decrease of 8.28%.
- For Other Income, as of Jun 2025, the value is 0.79 Cr.. The value appears to be declining and may need further review. It has decreased from 1.41 Cr. (Mar 2025) to 0.79 Cr., marking a decrease of 0.62 Cr..
- For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.41 Cr. (Mar 2025) to 0.24 Cr., marking a decrease of 0.17 Cr..
- For Depreciation, as of Jun 2025, the value is 2.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.54 Cr. (Mar 2025) to 2.52 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.69 Cr.. The value appears to be declining and may need further review. It has decreased from 6.53 Cr. (Mar 2025) to -0.69 Cr., marking a decrease of 7.22 Cr..
- For Tax %, as of Jun 2025, the value is -26.09%. The value appears to be improving (decreasing) as expected. It has decreased from 24.81% (Mar 2025) to -26.09%, marking a decrease of 50.90%.
- For Net Profit, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 6.20 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 6.18 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.03. The value appears to be declining and may need further review. It has decreased from 8.32 (Mar 2025) to 0.03, marking a decrease of 8.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 147 | 181 | 194 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 132 | 181 | 187 |
| Expenses | 134 | 159 | 161 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 167 | 173 |
| Operating Profit | 13 | 22 | 32 | 17 | 15 | -11 | -5 | -14 | -18 | 16 | 6 | 14 | 14 |
| OPM % | 9% | 12% | 17% | 14% | 10% | -12% | -5% | -14% | -15% | 9% | 5% | 8% | 7% |
| Other Income | 10 | 15 | 4 | 12 | 6 | 2 | -0 | 87 | 8 | 17 | 24 | 6 | 6 |
| Interest | 1 | 0 | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 | 2 |
| Depreciation | 2 | 5 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 | 10 |
| Profit before tax | 20 | 32 | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 18 | 8 | 8 |
| Tax % | 24% | 28% | 35% | 24% | 27% | -48% | 0% | 13% | 0% | 16% | 27% | 27% | |
| Net Profit | 16 | 23 | 22 | 25 | 14 | -13 | -23 | 51 | -18 | 20 | 14 | 9 | 9 |
| EPS in Rs | 20.94 | 31.24 | 29.34 | 33.43 | 18.32 | -16.92 | -30.76 | 68.02 | -24.20 | 26.94 | 18.65 | 12.11 | 11.56 |
| Dividend Payout % | 12% | 10% | 10% | 9% | 14% | -15% | -8% | 4% | 0% | 15% | 11% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 43.75% | -4.35% | 13.64% | -44.00% | -192.86% | -76.92% | 321.74% | -135.29% | 211.11% | -30.00% | -35.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -48.10% | 17.98% | -57.64% | -148.86% | 115.93% | 398.66% | -457.03% | 346.41% | -241.11% | -5.71% |
Dai Ichi Karkaria Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 11% |
| 3 Years: | 14% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 19% |
| 3 Years: | 33% |
| TTM: | 349% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 0% |
| 3 Years: | -7% |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 3% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 3:06 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 76 | 70 | 59 | 75 | 65 | 70 | 89 | 53 | 53 | 62 | 60 |
| Inventory Days | 51 | 53 | 51 | 78 | 74 | 98 | 104 | 133 | 93 | 59 | 77 | 60 |
| Days Payable | 76 | 94 | 82 | 68 | 83 | 128 | 146 | 210 | 122 | 87 | 74 | 75 |
| Cash Conversion Cycle | 50 | 34 | 39 | 70 | 66 | 36 | 28 | 11 | 24 | 25 | 65 | 45 |
| Working Capital Days | 45 | 43 | 52 | 67 | 54 | -9 | -38 | 27 | 13 | 4 | 21 | 36 |
| ROCE % | 17% | 23% | 28% | 17% | 8% | -7% | -4% | -8% | -12% | 8% | 0% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.11 | 18.65 | 26.94 | -24.20 | 68.03 |
| Diluted EPS (Rs.) | 12.11 | 18.65 | 26.94 | -24.20 | 68.03 |
| Cash EPS (Rs.) | 21.92 | 30.50 | 34.79 | -20.44 | 76.44 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 252.56 | 242.63 | 228.05 | 201.21 | 199.42 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 252.56 | 242.63 | 228.05 | 201.21 | 199.42 |
| Revenue From Operations / Share (Rs.) | 243.46 | 176.62 | 246.90 | 163.54 | 130.76 |
| PBDIT / Share (Rs.) | 25.40 | 13.53 | 29.97 | -18.77 | -11.56 |
| PBIT / Share (Rs.) | 11.77 | 1.14 | 19.97 | -27.89 | -22.98 |
| PBT / Share (Rs.) | 11.37 | 24.66 | 29.68 | -29.57 | 74.94 |
| Net Profit / Share (Rs.) | 8.29 | 18.11 | 24.79 | -29.57 | 65.02 |
| NP After MI And SOA / Share (Rs.) | 12.11 | 18.66 | 26.94 | -24.20 | 68.03 |
| PBDIT Margin (%) | 10.43 | 7.66 | 12.13 | -11.47 | -8.83 |
| PBIT Margin (%) | 4.83 | 0.64 | 8.08 | -17.05 | -17.57 |
| PBT Margin (%) | 4.66 | 13.96 | 12.02 | -18.08 | 57.30 |
| Net Profit Margin (%) | 3.40 | 10.25 | 10.04 | -18.08 | 49.72 |
| NP After MI And SOA Margin (%) | 4.97 | 10.56 | 10.91 | -14.79 | 52.02 |
| Return on Networth / Equity (%) | 4.79 | 7.68 | 11.81 | -12.02 | 34.11 |
| Return on Capital Employeed (%) | 4.59 | 0.46 | 7.84 | -13.26 | -11.34 |
| Return On Assets (%) | 3.88 | 6.25 | 8.11 | -8.41 | 23.34 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| Total Debt / Equity (X) | 0.06 | 0.10 | 0.22 | 0.14 | 0.13 |
| Asset Turnover Ratio (%) | 0.79 | 0.56 | 0.83 | 0.59 | 0.39 |
| Current Ratio (X) | 1.69 | 1.37 | 1.19 | 1.18 | 1.40 |
| Quick Ratio (X) | 1.23 | 0.93 | 0.85 | 0.78 | 1.03 |
| Inventory Turnover Ratio (X) | 10.12 | 4.43 | 5.51 | 3.62 | 3.13 |
| Dividend Payout Ratio (NP) (%) | 16.51 | 21.43 | 0.00 | -12.42 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 7.77 | 12.88 | 0.00 | -19.94 | 0.00 |
| Earning Retention Ratio (%) | 83.49 | 78.57 | 0.00 | 112.42 | 0.00 |
| Cash Earning Retention Ratio (%) | 92.23 | 87.12 | 0.00 | 119.94 | 0.00 |
| Interest Coverage Ratio (X) | 10.34 | 3.29 | 7.35 | -9.38 | -0.93 |
| Interest Coverage Ratio (Post Tax) (X) | 3.54 | -1.32 | 3.70 | -13.95 | -2.66 |
| Enterprise Value (Cr.) | 179.68 | 392.80 | 299.51 | 288.20 | 226.70 |
| EV / Net Operating Revenue (X) | 0.99 | 2.99 | 1.63 | 2.37 | 2.33 |
| EV / EBITDA (X) | 9.50 | 38.97 | 13.41 | -20.62 | -26.33 |
| MarketCap / Net Operating Revenue (X) | 0.97 | 2.89 | 1.47 | 2.24 | 2.28 |
| Retention Ratios (%) | 83.48 | 78.56 | 0.00 | 112.42 | 0.00 |
| Price / BV (X) | 0.94 | 2.10 | 1.59 | 1.82 | 1.49 |
| Price / Net Operating Revenue (X) | 0.97 | 2.89 | 1.47 | 2.24 | 2.28 |
| EarningsYield | 0.05 | 0.03 | 0.07 | -0.06 | 0.22 |
After reviewing the key financial ratios for Dai Ichi Karkaria Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.11. This value is within the healthy range. It has decreased from 18.65 (Mar 24) to 12.11, marking a decrease of 6.54.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.11. This value is within the healthy range. It has decreased from 18.65 (Mar 24) to 12.11, marking a decrease of 6.54.
- For Cash EPS (Rs.), as of Mar 25, the value is 21.92. This value is within the healthy range. It has decreased from 30.50 (Mar 24) to 21.92, marking a decrease of 8.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 252.56. It has increased from 242.63 (Mar 24) to 252.56, marking an increase of 9.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 252.56. It has increased from 242.63 (Mar 24) to 252.56, marking an increase of 9.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 243.46. It has increased from 176.62 (Mar 24) to 243.46, marking an increase of 66.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 25.40. This value is within the healthy range. It has increased from 13.53 (Mar 24) to 25.40, marking an increase of 11.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.77. This value is within the healthy range. It has increased from 1.14 (Mar 24) to 11.77, marking an increase of 10.63.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.37. This value is within the healthy range. It has decreased from 24.66 (Mar 24) to 11.37, marking a decrease of 13.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.29. This value is within the healthy range. It has decreased from 18.11 (Mar 24) to 8.29, marking a decrease of 9.82.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.11. This value is within the healthy range. It has decreased from 18.66 (Mar 24) to 12.11, marking a decrease of 6.55.
- For PBDIT Margin (%), as of Mar 25, the value is 10.43. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 10.43, marking an increase of 2.77.
- For PBIT Margin (%), as of Mar 25, the value is 4.83. This value is below the healthy minimum of 10. It has increased from 0.64 (Mar 24) to 4.83, marking an increase of 4.19.
- For PBT Margin (%), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 10. It has decreased from 13.96 (Mar 24) to 4.66, marking a decrease of 9.30.
- For Net Profit Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 5. It has decreased from 10.25 (Mar 24) to 3.40, marking a decrease of 6.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 8. It has decreased from 10.56 (Mar 24) to 4.97, marking a decrease of 5.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.79. This value is below the healthy minimum of 15. It has decreased from 7.68 (Mar 24) to 4.79, marking a decrease of 2.89.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.59. This value is below the healthy minimum of 10. It has increased from 0.46 (Mar 24) to 4.59, marking an increase of 4.13.
- For Return On Assets (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 5. It has decreased from 6.25 (Mar 24) to 3.88, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.06, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has increased from 0.56 (Mar 24) to 0.79, marking an increase of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 1.69. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.69, marking an increase of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has increased from 0.93 (Mar 24) to 1.23, marking an increase of 0.30.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.12. This value exceeds the healthy maximum of 8. It has increased from 4.43 (Mar 24) to 10.12, marking an increase of 5.69.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 16.51. This value is below the healthy minimum of 20. It has decreased from 21.43 (Mar 24) to 16.51, marking a decrease of 4.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.77. This value is below the healthy minimum of 20. It has decreased from 12.88 (Mar 24) to 7.77, marking a decrease of 5.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 83.49. This value exceeds the healthy maximum of 70. It has increased from 78.57 (Mar 24) to 83.49, marking an increase of 4.92.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.23. This value exceeds the healthy maximum of 70. It has increased from 87.12 (Mar 24) to 92.23, marking an increase of 5.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has increased from 3.29 (Mar 24) to 10.34, marking an increase of 7.05.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.54. This value is within the healthy range. It has increased from -1.32 (Mar 24) to 3.54, marking an increase of 4.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 179.68. It has decreased from 392.80 (Mar 24) to 179.68, marking a decrease of 213.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has decreased from 2.99 (Mar 24) to 0.99, marking a decrease of 2.00.
- For EV / EBITDA (X), as of Mar 25, the value is 9.50. This value is within the healthy range. It has decreased from 38.97 (Mar 24) to 9.50, marking a decrease of 29.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 2.89 (Mar 24) to 0.97, marking a decrease of 1.92.
- For Retention Ratios (%), as of Mar 25, the value is 83.48. This value exceeds the healthy maximum of 70. It has increased from 78.56 (Mar 24) to 83.48, marking an increase of 4.92.
- For Price / BV (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 2.10 (Mar 24) to 0.94, marking a decrease of 1.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 2.89 (Mar 24) to 0.97, marking a decrease of 1.92.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dai Ichi Karkaria Ltd:
- Net Profit Margin: 3.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.59% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.79% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.23
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.4 (Industry average Stock P/E: 64.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.4%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Liberty Building, Mumbai Maharashtra 400020 | investor@dai-ichiindia.com http://www.dai-ichiindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Shernaz Vakil | Chairperson & Whole Time Director |
| Ms. Meher Vakil Taff | Managing Director |
| Mr. Adi Jehangir | Non Executive Director |
| Mr. Behram Sorabji | Independent Director |
| Mr. Srinivasan Vishwanathan | Independent Director |
| Mr. Ashok Hiremath | Independent Director |